With these associations, the designation of ATM as BRCA3 (Breast Cancer 3) could be suggested; in fact, greater information and clinical management guidelines are already included in the National Comprehensive Cancer Network® (NCCN) guidelines for mutations in this gene. The gene discussed is ATM; the disease is breast carcinoma.